On August 6, VTEX (NYSE:VTEX) reported second-quarter results that read as two different companies stapled together. Profitability jumped by double digits, free cash flow nearly doubled, and the company kept buying back its own stock. At the same time, the growth engine that used to justify VTEX’s story cooled off sharply once currency swings are stripped out. Investors now have to decide which trend matters more.
Profits Are Finally Catching Up
VTEX’s bottom line moved a lot faster than its top line this quarter. Non-GAAP income from operations climbed 62.4% year over year to $13.8 million, pushing the operating margin to 21.4%. Non-GAAP net income rose to $13.6 million from $7.9 million a year earlier, and free cash flow jumped 79.1% to $12.7 million, a 19.8% margin. Subscription gross margin, the profitability of VTEX’s core business, widened to 81.8% from 79.9%, and subscription gross profit grew 14.1% to $52.2 million. None of that came from spending more to get it: total headcount fell 14.1% year over year to 1,102 employees, even as VTEX repurchased 6.2 million shares for $23.2 million during the quarter.
Beneath those headline numbers, VTEX pointed to its four growth drivers, Global Expansion, B2B, Ads, and AI, growing faster than the company overall. New enterprise customers signed on across a wide range of industries and countries, from Dolce & Gabbana’s first official ecommerce channel in Brazil to Iberdrola in Spain and Acron Aviation’s specialized parts and diagnostics stores in the US. The advertising business is showing real traction too: Farmacity scaled its on-site ad investment 2.4x while its conversion rate grew over 70%, and Sanofi ran 96 campaigns with a return on ad spend above 7x.
The Core Growth Problem
Strip out currency effects, and the growth story looks far less exciting. Total revenue rose 9.5% in reported dollars to $64.4 million, but actually fell 0.4% on an FX-neutral basis. Subscription revenue, 99.1% of VTEX’s business, grew just 1.3% FX-neutral in the quarter, down sharply from 11.2% growth in the same period last year. Over the first six months of 2026, FX-neutral subscription revenue growth ran at 2.7%, less than a quarter of the 13.0% pace set in the first half of 2025. GMV growth on the same basis slowed to 7.0% from 13.6% a year earlier.
Management’s own outlook doesn’t paint a much brighter picture. VTEX is now targeting roughly flat FX-neutral subscription revenue growth for the third quarter and only low-single-digit growth for full-year 2026, citing weaker consumption trends in Brazil during June and July along with a continued shift toward larger enterprise accounts. The company also disclosed that if exchange rates hold at July’s levels, currency alone would add about 7.0 percentage points to third-quarter reported subscription revenue growth and 8.1 points for the full year, meaning a meaningful share of any headline growth ahead may have little to do with the underlying business.
What The Market Is Pricing In
Hedge fund ownership of VTEX rose from 16 funds to 25 in the most recent quarter, pointing to institutions adding rather than trimming positions. Short interest sits at 6.70% of the float, enough to suggest a real bear camp has formed around the stock. VTEX trades at a forward P/E of 21.64, as of September 9, a multiple that assumes meaningful earnings growth ahead even as FX-neutral revenue growth has nearly stalled.
Two Stories, One Stock
VTEX heads into the second half of 2026 pulling in two directions at once. Profitability, cash flow, and capital discipline all improved sharply, and the company kept landing enterprise customers across new markets and product lines. But the core subscription business, once growing in the low teens on an FX-neutral basis, has slowed to barely more than flat. For the profit story to keep compounding, that underlying growth needs to firm up soon.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Hedge Fund Resource Center